Acumetis names Ramil Burden CEO as founder Brent Herspiegel joins board

DFW Capital Partners portfolio company Acumetis named Ramil Burden chief executive officer, effective Sept. 14, 2026. Founder Brent Herspiegel stepped down as CEO, moved to the board to support the leadership transition. Burden previously served as CEO of Optum Life Sciences, spent 17 years at GSK in senior commercial, strategy roles. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DFW Capital Partners LP published the original content used to generate this news brief on October 12, 2026, and is solely responsible for the information contained therein. (C)